Home blood pressure monitoring was considered as outpatient follow ... CONSORT (Consolidated Standards of Reporting Trials) flowchart recruitment of participants. Baseline characteristics were similar ...

Study flow chart. Arg indicates argatroban ... Subgroup analysis (predefined for age, sex, hypertension, diabetes, hyperlipidemia, smoking, NIHSS score, and onset-to-randomization) was performed to ...

This repository demonstrates the transformative potential of rule-based expert systems in healthcare, particularly in enhancing patient self-care and improving the clinical management of heart failure ...

Hypertension, known as High Blood Pressure in layman language, occurs when the force of blood against the artery walls is consistently too high. On a global level, this has been set to any reading ...

Hypertension remains a significant public health concern worldwide, contributing to a substantial burden of cardiovascular disease and related mortality and leading to an annual health care cost ...

Apr. 30, 2025 — Investigators have discovered a new pathway that may lead to a treatment for high blood pressure and aortic aneurysms. By creating a new laboratory model for studying these ...

One of the most common symptoms of dangerously high blood pressure is a severe headache. This headache is usually sudden and intense, unlike normal headaches. It can feel like a pounding or ...

Hypertension affects nearly half of American adults, often developing silently until it leads to serious health complications. While medication remains a cornerstone of treatment for many, growing ...

HemiClor is expected to be available in pharmacies starting in May 2025. The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the ...

"This study was designed to look at the impact of a novel medication in lowering blood pressure for individuals whose hypertension is inadequately controlled by current standard medications," said ...

Many people diagnosed with hypertension are prescribed angiotensin-converting enzyme inhibitors—better known as ACE-1 inhibitors (ACEIs)—and/or angiotensin receptor blockers (ARBs), which act ...